Sharps Technology Inc. is a company focused on developing innovative solutions for the safe handling and disposal of sharps waste, particularly in the healthcare sector
Its primary mission is to reduce the risks associated with needle stick injuries and the environmental impacts of improper disposal of sharp medical instruments. The company creates advanced products and systems that enhance safety and efficiency in the management of sharps, aiming to improve patient care while ensuring compliance with health regulations. By prioritizing sustainability and safety, Sharps Technology Inc. contributes to better health outcomes and environmental stewardship.
Sharps (NASDAQSTSS), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products, has announced the closing of its firm commitment underwritten public offering. The company secured approximately $20.0 million in gross proceeds from the offering that closed on Jan. 29, 2025. The company granted Aegis Capital Corp. a 45-day option to purchase additional shares of common stock and/or warrants as detailed in the announcement. Aegis acted as the sole book-running manager for the offering. Sichenzia Ross Ference Carmel LLP acted as counsel to the company, and Kaufman & Canoles, P.C. acted as counsel to Aegis.
Curious to know what's happening on the US markets in the middle of the day on Tuesday? Join us as we explore the top gainers and losers in today's session.
Sharps Technology Inc. (NASDAQSTSS) has closed a secured bridge loan financing of approximately $3.5 million. Investors purchased $4.375 million in aggregate principal amount of secured notes along with 5.7 million shares of common stock. The company plans to use the funds, combined with existing cash, for general corporate purposes and working capital. Aegis Capital Corp. served as the exclusive placement agent for the private placement, which was offered solely to accredited investors.
NEW YORK, NY / ACCESSWIRE / September 27, 2024 / Aegis Capital Corp. acted as Exclusive Placement Agent on a $3.5 Million Bridge Financing for Sharps Technology, Inc. (NASDAQSTSS).
Shares of NIO Inc. (NYSENIO) fell sharply during Friday's session after the company disclosed that Steven Wei Feng has resigned as the Chief Financial Officer for personal and family
Sharps Technology shares surge as the company receives orders for 1 million SecureGard syringes from a Swiss provider of injectable therapies. First shipment in July; subsequent deliveries through 2024.
Shares of Sharps Technology, Inc. (NASDAQSTSS) rose sharply in today's pre-market trading after the company announced it received two purchase orders for a total of approximately one million SecureGard syringes for 2024 delivery.
